Success Metrics

Clinical Success Rate
100.0%

Based on 4 completed trials

Completion Rate
100%(4/4)
Active Trials
4(40%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_1
1
10%
Ph not_applicable
9
90%

Phase Distribution

1

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution10 total trials
Phase 1Safety & dosage
1(10.0%)
N/ANon-phased studies
9(90.0%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

100.0%

4 of 4 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

4

trials recruiting

Total Trials

10

all time

Status Distribution
Active(4)
Completed(4)
Other(2)

Detailed Status

Completed4
Recruiting3
unknown2
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
10
Active
4
Success Rate
100.0%
Most Advanced
Phase 1

Trials by Phase

Phase 11 (10.0%)
N/A9 (90.0%)

Trials by Status

recruiting330%
completed440%
unknown220%
active_not_recruiting110%

Recent Activity

Clinical Trials (10)

Drug Details

Intervention Type
BEHAVIORAL
Total Trials
10